Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Oaktree Capital Management
Quarter-by-quarter ownership of Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Oaktree Capital Management
from 13F filings
Historical chart of Oaktree Capital Management investment in Intercept Pharmaceuticals In Note 2.000 5/1 bnd
Tip: Access up to 7 years of quarterly data
All positions including Intercept Pharmaceuticals In Note 2.000 5/1 bnd held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intercept Pharmaceuticals In Note 2.000 5/1 bnd by Oaktree Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $7.2M | 7.3M | 0.99 |
2023-06-30 | $9.5M | 12M | 0.80 |
2023-03-31 | $7.3M | 8.8M | 0.83 |
2022-12-31 | $6.3M | 8.4M | 0.75 |
2022-09-30 | $4.5M | 5.9M | 0.76 |
More positions owned by Oaktree Capital Management
View all positions for Oaktree Capital Management
Top funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd
View all funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd